Supplementary Data 1 from Investigation of PARP Inhibitor Resistance Based on Serially Collected Circulating Tumor DNA in Patients With <i>BRCA</i>-Mutated Ovarian Cancer

Abstract

&lt;p&gt;Supplementary Methods Supplementary Figure 1-5 Supplementary Table 1-2&lt;/p&gt;